Correction: SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury
Meng-Li Wu, Feng-Liang Liu, Jing Sun, Xin Li, Xiao-Yan He, Hong-Yi Zheng, Yan-Heng Zhou, Qihong Yan, Ling Chen, Guo-Ying Yu, Junbiao Chang, Xia Jin, Jincun Zhao, Xin-Wen Chen, Yong-Tang Zheng, Jian-Hua Wang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMast cells and histamine · IL-33, ST2, and ILC Pathways · Phagocytosis and Immune Regulation
Correction to: Signal Transduction and Targeted Therapy 10.1038/s41392-021-00849-0, published online 17 December 2021
After the publication of this review article^1^, a miscitation was identified in the Introduction part. In the sentence “Besides, US FDA has approved and authorized two mRNA vaccines (Pfizer-BioNTech, Moderna) and one recombinant adenovirus-26 vaccine (Janssen, Ad26.COV2.S) for population use,5 and globally more than 100 candidate SARS-CoV-2 vaccines are under development 6”, the reference 5 bearing no relevance to vaccine approvals was cited by an inadvertent mistake. Therefore, this reference should be removed. We apologize for any inconvenience this has caused. The key findings of the article are not affected by this correction.
The original article has been corrected.